Skip to main navigation Skip to search Skip to main content

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder

  • Michael Van Ameringen
  • , Naomi A. Fineberg
  • , Arun Ravindran
  • , Paul D. Arnold
  • , Serge Beaulieu
  • , Vlasios Brakoulias
  • , Elisa Brietzke
  • , Yekta Dowlati
  • , Lynne M. Drummond
  • , Casara J. Ferretti
  • , Jamie D. Feusner
  • , Rafael C.R. Freire
  • , Benicio N. Frey
  • , Sarah Gardiner
  • , Daniel A. Geller
  • , Peter Giacobbe
  • , Carolina Goldman Bergmann
  • , Giacomo Grassi
  • , Erica Greenberg
  • , Eric Hollander
  • Paige Hopkinson, Sidney H. Kennedy, Raymond W. Lam, Christine Lochner, Joseph F. McGuire, Sarah McQuay, Jose M. Menchon, Roumen Milev, Luciano Minuzzi, Juliette Mojgani, Davis N. Mpavaenda, Humberto Nicolini, Stefano Pallanti, Ilenia Pampaloni, Sagar V. Parikh, Beth Patterson, Lakshmi Ravindran, Jemma Reid, Carolyn I. Rodriguez, Zainab Samaan, Ayal Schaffer, Lukasz Smigielski, Valerie H. Taylor, Smadar Valérie Tourjman, Peter van Roessel, Simone N. Vigod, Susanne Walitza, Lakshmi N. Yatham, Joseph Zohar, Morená Zugliani, Bernardo Maria Dell’Osso
  • Department of Psychiatry and Behavioural Neurosciences
  • McMaster University
  • School of Life and Medical Sciences
  • University of Hertfordshire
  • Hertfordshire Partnership University NHS Foundation Trust
  • Department of Psychiatry
  • University of Toronto
  • Department of Pharmacology and Toxicology
  • The Mathison Centre for Mental Health Research & Education
  • University of Calgary
  • McGill University
  • Douglas Mental Health University Institute
  • The University of Sydney
  • Queen's University Kingston
  • Kingston General Hospital Research Institute
  • Independent Researcher
  • South West London and St Georges NHS Trust
  • Department of Psychiatry and Behavioral Sciences
  • Albert Einstein College of Medicine
  • Autism and Obsessive Compulsive Spectrum Program
  • Psychiatric Research Institute of Montefiore-Einstein (PRIME)
  • Laboratory of Panic and Respiration
  • Universidade Federal do Rio de Janeiro
  • Women's Health Concerns Clinic
  • Department of Psychiatry
  • Harvard University
  • Massachusetts General Hospital
  • University of British Columbia
  • Brain Center Firenze
  • MacAnxiety Research Centre
  • Western University
  • Department of Psychiatry
  • Risk and Resilience in Mental Disorders Research Unit
  • Johns Hopkins University
  • Royal College of Surgeons in Ireland
  • Department of Psychiatry
  • Hospitalet de Llobregat
  • Department of Clinical Sciences Faculty of Medicine
  • Biomedical Research Networking Center for Mental Health Network (CiberSAM)
  • Department of Psychiatry and Psychology
  • Providence Care Hospital
  • South West London and St George's Mental Health NHS Trust
  • Lab Enfermedades Psiquiátricas
  • Instituto Nacional de Medicina Genomica
  • Outpatient Clinic
  • Institute for Neurosciences
  • University of Michigan, Ann Arbor
  • Department of Psychiatry
  • Cornwall Partnership NHS Foundation Trust
  • Department of Psychiatry and Behavioral Sciences
  • Stanford University
  • Department of Veterans Affairs
  • Department of Child and Adolescent Psychiatry and Psychotherapy
  • University of Zurich
  • Department of Addiction and Mental Health
  • University of Montreal
  • Montreal University Institute of Mental Health
  • Department of Psychiatry
  • Sheba Medical Center at Tel Hashomer
  • Neuroscience Research Center
  • University of Milan

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Background: As a joint effort by the Canadian Network for Mood and Anxiety Treatments (CANMAT) and the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS), these treatment guidelines provide an up-to-date synthesis of published literature on the efficacy, safety, and tolerability of the range of interventions available for the management of obsessive-compulsive disorder (OCD) across the lifespan. The primary goal is to provide clear, easy to use recommendations for practicing clinicians. Methods: A global group of OCD experts were divided into panels to develop specific sections based on internal group discussions and the evidence extracted from systematic literature searches. CANMAT-defined Levels of Evidence, as well as level of clinical support were used to inform Lines of Treatment and final treatment recommendations. Drafts were revised based on feedback from individuals with lived experience, expert peer review, and a defined expert consensus process. Results: These OCD Guidelines include seven sections spanning foundations of management and diagnosis, psychological, pharmacological, and neuro-modulation treatment modalities, treatment resistance, children and adolescents, special populations and future directions. Recommendations are summarized in tables for ease of reference and caveats and limitations of the current evidence are discussed. Conclusions: The CANMAT/ICOCS 2025 OCD International Guidelines synthesize the evidence on the efficacy, safety, and tolerability of the range of interventions available for the management of OCD. It is anticipated that these new OCD guidelines will enable psychiatrists and other clinicians to provide systematic, evidence-based care for their patients with OCD across the lifespan.

Original languageEnglish
Pages (from-to)404-488
Number of pages85
JournalJournal of Psychiatric Research
Volume199
DOIs
Publication statusPublished - Aug 2026
Externally publishedYes

Fingerprint

Dive into the research topics of 'Canadian Network for Mood and Anxiety Treatments (CANMAT) and International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) 2025 international guidelines for the management of patients with obsessive-compulsive disorder'. Together they form a unique fingerprint.

Cite this